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Abstract
Yersinia pseudotuberculosis is a Gram-negative bacterium capable of causing gastrointestinal infection and is closely related 
to the highly virulent plague bacillus Yersinia pestis. Infections by both species are currently treatable with antibiotics such 
as ciprofloxacin, a quinolone-class drug of major clinical importance in the treatment of many other infections. Our current 
understanding of the mechanism of action of ciprofloxacin is that it inhibits DNA replication by targeting DNA gyrase, and that 
resistance is primarily due to mutation of this target site, along with generic efflux and detoxification strategies. We utilized 
transposon-directed insertion site sequencing (TraDIS or TnSeq) to identify the non-essential chromosomal genes in Y. pseudo-
tuberculosis that are required to tolerate sub-lethal concentrations of ciprofloxacin in vitro. As well as highlighting recognized 
antibiotic resistance genes, we provide evidence that multiple genes involved in regulating DNA replication and repair are 
central in enabling Y. pseudotuberculosis to tolerate the antibiotic, including DksA (yptb0734), a regulator of RNA polymerase, 
and Hda (yptb2792), an inhibitor of DNA replication initiation. We furthermore demonstrate that even at sub-lethal concentra-
tions, ciprofloxacin causes severe cell-wall stress, requiring lipopolysaccharide lipid A, O-antigen and core biosynthesis genes 
to resist the sub-lethal effects of the antibiotic. It is evident that coping with the consequence(s) of antibiotic-induced stress 
requires the contribution of scores of genes that are not exclusively engaged in drug resistance.
DATA SummARy
The authors confirm all supporting data and protocols have 
been provided within the article or through supplementary 
data files.
InTRoDuCTIon
Yersinia pseudotuberculosis is a facultatively anaerobic, Gram-
negative pathogen of humans and animals, capable of causing 
fever and acute gastrointestinal infection, yersiniosis, when 
transmitted by the faecal–oral route [1]. In rare instances, 
infection can result in septicaemia, which carries an associ-
ated risk of mortality [1]. Most cases of enteric disease caused 
by Y. pseudotuberculosis are self-limiting and do not require 
treatment, although there is some evidence that antibiotics 
can reduce faecal shedding, potentially reducing the risk of 
transmission [2, 3]. Some Y. pseudotuberculosis strains may 
express a superantigenic toxin causing Far Eastern Scarlett-
like fever, which is a childhood disease with rash, arthralgia 
and polyarthritis most commonly reported in eastern Russia, 
Korea and Japan [4]. There is also epidemiological evidence 
linking Y. pseudotuberculosis with Kawasaki disease in chil-
dren [1]. There are other rare immunological complications 
associated with enteric yersiniosis [4], which is why there 
is a requirement for diagnosis of what is usually a self-
limiting gastric infection. In cases with more serious clinical 
presentation, such as scarlet-like fever or sepsis, antibiotic 
therapy is required, usually with cefotaxime, ceftriaxone or 
ciprofloxacin.
In the Y. pseudotuberculosis genome, 75 % of the predicted 
genes are 97 % identical at the DNA level to their ortholo-
gous counterparts in Yersinia pestis, the causative agent of 
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bubonic and pneumonic plague [5]. If plague is suspected, 
antibiotic treatment is started immediately without waiting 
for laboratory confirmation and patients must be placed in 
isolation to reduce the risk of spread in the event of pneu-
monic plague developing. In the past, streptomycin has been 
the drug of choice for the treatment of plague, but the toxicity 
of streptomycin makes this less than ideal and ciprofloxacin 
has now been included in Centers for Disease Control and 
Prevention guidelines for therapy. The fluoroquinolone anti-
biotic levofloxacin was approved recently by the US Food and 
Drug Administration for the therapy or prophylaxis of plague 
infections, based on efficacy studies in African green monkeys 
[6]. Untreated, the case fatality rate is 40–60 %, but where 
therapy is used this can be reduced to around 14 %. Due to 
the high degree of genetic conservation and the fact that Y. 
pseudotuberculosis can be worked with at a lower biosafety 
containment level than Y. pestis, it is a useful surrogate for its 
more virulent relative.
While most Y. pseudotuberculosis clinical isolates are suscep-
tible to antibiotics that are active against Gram-negative 
bacteria [7, 8], multidrug-resistant (MDR) strains of Y. pseudo-
tuberculosis have occasionally been reported [9]. MDR strains 
of Y. pestis have also been reported, including mutations that 
confer resistance to ciprofloxacin [10]. While there is good 
evidence that mutation of DNA gyrase and topoisomerase – 
the key targets of fluoroquinolone activity – mediate resistance 
to this class of antibiotics in many bacteria, including Y. pestis 
[11], modification of the bacterial envelope by decreasing 
porin production or increasing the expression of efflux pump 
systems also contributes to the MDR phenotype. For example, 
AraC family regulators, such as MarA, can respond to antibi-
otic stress and confer MDR by increasing expression of the 
AcrAB-TolC multidrug efflux pump and MicF, a small regula-
tory RNA that down-regulates the ompF porin [12]. Mutation 
of MarA homologues in Y. pestis [13] resulted in increased 
susceptibility to a range of antibiotics, including ciprofloxacin. 
The combined action of these mechanisms confers a signifi-
cant decrease in bacterial sensitivity to therapy and favours the 
acquisition of additional mechanisms of resistance.
Thus, the bacterial response to antibiotic stress is more 
complex than merely the interaction of a single compound 
with a single target, and there is still much to be learned 
in the field of drug–pathogen interactions. Identifying and 
targeting the antibiotic stress regulon may be a valid strategy 
in improving the activity of currently used antibiotics. 
Transposon-directed insertion site sequencing (TraDIS or 
TnSeq) is an approach that can be used to elucidate genome-
wide essentiality under selective pressure. It has been applied 
to a range of pathogens to explore how bacteria cope with 
antibiotic stress, including Pseudomonas aeruginosa [14], 
Mycobacterium tuberculosis [15], Acinetobacter baumannii 
[16] and Klebsiella pneumoniae [17]. We recently constructed 
and validated a TraDIS library in Y. pseudotuberculosis to 
identify the genes required for growth in optimized in vitro 
conditions [18]. In the present work, we utilize this resource 
to establish, for the first time, the genes involved in resistance 
to ciprofloxacin stress in enterobacteria.
mETHoDS
Transposon sequencing
Y. pseudotuberculosis strain IP32953 was previously used to 
generate a transposon library of approximately 40 000 unique 
insertion mutants using the Ez-Tn5 Kan2 transposome 
complex (Epicentre) as described and validated by Willcocks 
et al. [18].
We first inoculated 15 ml pre-warmed BAB medium at 28 
°C from pooled frozen aliquots of the Y. pseudotuberculosis 
library and incubated this for 4 h before transferring 5 ml 
to 50 ml of fresh blood agar base 2 (BAB) liquid medium 
(ThermoScientific) for overnight incubation at 28 °C with 
shaking. From this medium, 3 ml was used to inoculate 50 
ml pre-warmed BAB medium in the absence or presence of 
ciprofloxacin for a further 24 h before extraction of genomic 
DNA (gDNA). Published minimum inhibitory concentra-
tions (MICs) of ciprofloxacin against Y. pseudotuberculosis 
vary [8, 19]; in our study, we treated the bacteria with 0.004 
µg ml−1, which is below the lowest reported MIC.
gDNA was extracted (ArchivePure DNA Extraction Kit, 
5Prime) and pooled from triplicate technical repeats and from 
triplicate biological repeats performed independently. Library 
preparation for Illumina MiSeq sequencing was performed 
as described by Willcocks et al. [18] and reads were mapped 
Impact Statement
Our understanding of the mechanism of action of many 
antibiotics tends to be restricted to a specific, singular 
target site that interacts directly with the compound. 
Beyond this, we can use transcriptomics to describe the 
response of microbes to treatment, which may capture 
some of the wider stresses exerted by the antibiotic. 
However it is unclear from such techniques which genes 
are essential for surviving the antibiotic stress, and which 
are just associated with the treatment. By sequencing 
a transposon library in Yersinia pseudotuberculosis 
subjected to sub-lethal concentrations of ciprofloxacin, 
we have identified all the genes required by the pathogen 
to tolerate this stress, as without functional versions of 
the gene(s), the mutants cannot survive. This approach 
has generated insightful data that show that dozens of 
genes normally involved in housekeeping functions are 
also critical in tolerating ciprofloxacin, including, surpris-
ingly, cell-wall lipopolysaccharide synthesis genes. Not 
only does this expand our understanding of how cipro-
floxacin causes toxicity in microbes, it also highlights 
mechanisms by which the bacteria can resist the anti-
biotic. This is important in developing future antimicro-
bials, a matter of pressing importance given the rise 
of antimicrobial resistance across multiple pathogens 
against many different classes of antibiotic.
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against the reference genome (European Molecular Biology 
Laboratory accession number: BX936398).
Curation of the list of ciprofloxacin tolerance genes
We sequenced bacteria from three different experimental 
conditions: directly from frozen stocks of the pooled trans-
poson library (unpassaged control); after passage in the 
absence of antibiotic (untreated, passaged control); and 
after passage in the presence of antibiotic (antibiotic-treated 
condition). To obtain a list of ciprofloxacin tolerance genes, 
we adapted the methodology of Eckert et al. [20]. We initially 
normalized the number of reads for each transposon inser-
tion site against the total number of reads within each condi-
tion. We then excluded any transposon mutants that were 
absent from the sequencing of the unpassaged control, as 
these represent essential fitness genes, regardless of treatment 
condition (this list was verified against the 488 published 
essential genes from our strain). We next calculated log2-fold 
change values for the untreated control against the unpas-
saged control, and excluded any genes that had lower than 
a −1 difference versus unpassaged control. Our preliminary 
list of ciprofloxacin tolerance genes was determined by iden-
tifying those transposon mutants that showed lower than −1 
log2-fold change in the treated versus untreated control. For 
mutants with zero reads in the antibiotic-treated condition, 
we applied an arbitrary value of 0.5 reads to enable a log2 
calculation. We next performed the non-parametric permuta-
tion statistical analysis test, also known as the randomization 
test, to assign P-values to each gene, as described previously 
[21, 22], removing any that were not significantly differently 
represented between the two conditions (P<0.05). For the 
main list of ciprofloxacin tolerance genes, we only included 
genes where we identified at least ten total reads per gene 
following passage in the untreated condition. We separately 
collated genes with a read count of 2–10; while this second 
list must be interpreted with more caution, we hypothesized 
that it may contain transposon mutants that suffered a general 
fitness handicap that is exacerbated under the additional 
stress of antibiotic treatment. A representative gene from each 
of these two categories of ciprofloxacin tolerance genes was 
chosen for subsequent mutagenesis and phenotypic analysis 
(dksa >10 reads; hda <10 reads).
Creation of targeted isogenic mutants
In order to create targeted mutants to validate our TraDIS 
findings, we used a lambda Red recombination approach, by 
which the gene of interest was replaced with a kanamycin 
resistance cassette (adapted from Datsenko et al. [23]). We 
have summarized the method in diagrammatic form in Fig. 
S1 (available in the online version of this article).
Y. pseudotuberculosis IP32956 pDK46 served as the recipient 
strain for mutagenesis (kindly provided by Professor Richard 
Titball, Exeter University). This strain was maintained at 28 
°C in the presence of 0.2 % arabinose and ampicillin in BAB 
medium. The kanamycin resistance cassette was amplified 
from pKD4 by the PCR, with primers designed to incorporate 
the nucleotide sequence flanking the gene of interest (Table 
S1). The purified PCR product was subsequently DpnI-
digested and used to transform the recipient strain, integra-
tion being mediated by lambda Red-induced homologous 
recombination. These strains were subsequently maintained at 
37 °C, at which temperature the temperature-sensitive pDK46 
plasmid is lost, and were grown thereafter in the presence of 
50 µg kanamycin ml−1. After curing the pDK46 plasmid from 
the strain, we could ensure that kanamycin resistance was due 
to chromosomally integrated gene recombination. To confirm 
the null allele, PCR with primers for the gene of interest was 
conducted on gDNA extracted from individual colonies, 
which were subsequently confirmed by Sanger sequencing.
Bacterial culture conditions and in vitro assays
Growth curve analysis was conducted using a fresh aliquot 
from an overnight culture at 28 °C diluted 1 : 50 in pre-
warmed, sterile BAB medium. Optical density at 600 nm was 
determined at the time points described.
Antibiotic susceptibility of mutants to a fixed concentra-
tion of ciprofloxacin, moxifloxacin, chloramphenicol and 
tetracycline (0.05 µg ml−1) was assessed using the alamar 
blue assay (Thermo Fisher Scientific). This assay is indica-
tive of cell viability by virtue of reduction of the reagent by 
the metabolic processes of living cells, causing a quantifiable 
colour change. For absolute viability, we also performed a 
c.f.u. assay using a titration of ciprofloxacin (0–0.1 µg ml−1). 
Fresh cultures were aliquoted into 96-well plates at 1×107 c.f.u. 
mL−1 final concentration in BAB medium with or without 
antibiotic supplementation. Alamar blue reagent was added 
at 1 : 20 (v/v) and the optical density was recorded at 540 
nm and at 620 nm at selected time points. Relative metabolic 
activity was calculated first by normalizing 540 nm values 
against 620 nm values and the bacteria-free control samples 
as per the manufacturer’s instructions, and finally by normal-
izing these values against the untreated bacteria condition. 
We confirmed the sensitivity of the strains to ciprofloxacin 
by measuring absolute viability through serial dilution of the 
bacteria in sterile PBS and enumerating colony-forming units 
from growth on Yersinia selective agar at 28 °C. Sensitivity of 
the mutants to hydrogen peroxide (H2O2), cumyl hydroper-
oxide and hydroxyurea (HU; all from Sigma) was examined 
by incubating bacteria at 5×106 c.f.u. ml−1 in a 96-well plate 
for 24 h with a titration of the chemical agents and assessing 
optical density at 540 nm.
RAW 264.7 culture conditions
Infection of murine macrophage-like RAW 264.7 cells was 
used to assess the resistance of the mutants to innate immune 
killing. Cells were grown and maintained in Gibco RPMI 
1640 Glutamax (Thermo Fisher Scientific) with 10 % FBS 
(Thermo Fisher Scientific) at 37 °C and 5 % CO2. In total, 
1×105 cells ml−1 were aliquoted into flat 96-well plates with 
the addition of 0.1 µg ml−1 recombinant murine IFNγ (RND 
Systems) and incubated overnight. Wild-type IP32956 and 
mutants were cultured overnight as previously described and 
inoculated at an m.o.i. of 0.1. RAW 264.7 cells with bacteria 
were incubated for 90 min to allow intracellular infection. 
4Willcocks et al., Microbial Genomics 2019
Media and extracellular bacteria were removed and cells were 
washed three times with sterile PBS before fresh medium was 
added containing 100 µg imipenem ml−1 (Sigma). After 16 h, 
cells were lysed with 0.1 % Triton X100 in sterile, molecular-
grade water for 10 min before manual disruption by pipetting 
and serial dilution of the resultant lysate for the c.f.u. assay. 
As a marker of cell activation state, we harvested cell culture 
supernatant at various time points and inferred nitric oxide 
production through the quantification of nitrite by a Griess 
Assay (Thermo Fisher Scientific) according to the manufac-
turer’s instructions.
Galleria mellonella larvae infection
Galleria mellonella larval infection is an increasingly popular 
tool for in vivo microbiological research [24]. Larvae were 
purchased from Livefoods Direct and stored at 10 °C before 
use. Bacteria were cultured overnight in Lysogeny Broth (LB) 
at 37 °C and 210 r.p.m. Cultures were diluted in PBS to 108 
c.f.u. ml−1, and 10 µl was injected into the foremost left pro-leg 
using a 25 µl syringe (Hamilton). Actual challenge dose in the 
input was established by retrospective viable counts. A control 
group was injected with 10 µl PBS to control for mortality 
caused by handling and injection. After injection of ten larvae 
per group, they were kept in sterile Petri dishes in the dark at 
37 °C and survival was assessed at 24 and 48 h post-infection. 
The bacterial burden of survivors was determined by calcu-
lating the c.f.u. ml−1 contained in the larvae haemolymph after 
48 h. Individual larvae were placed in microcentrifuge tubes 
and kept on ice until they were comatose. Haemolymph was 
collected by cutting off 2 mm of the tail tip of the larva and 
allowing the contents to drain into the microcentrifuge tube 
while still on ice. Haemolymph was diluted 1 : 10 in sterile 
PBS and serial ten-fold dilutions were performed. Dilutions 
were spread onto LB agar and incubated at 37 °C for 72 h, and 
c.f.u. ml−1 values were calculated.
RESuLTS
Identification of ciprofloxacin tolerance genes
TraDIS detects at the genome level the genes required for 
survival and replication under defined experimental condi-
tions. We have exploited this to identify genes of interest 
following treatment of a TraDIS library of Y. pseudotubercu-
losis with a sub-MIC concentration (0.004 µg ml−1) of cipro-
floxacin for 24 h. Bacteria carrying a transposon insertion in 
a gene that is required for survival are negatively selected from 
the pooled library, and have fewer reads upon next-generation 
sequencing of the pooled extracted gDNA.
The complete list of 326 ciprofloxacin tolerance genes with 
at least −1 log2-fold change can be found in Table S2 (for 
mutants with at least ten reads in the untreated passaged 
condition) and Table S3 (for mutants with fewer than ten 
reads in the untreated passaged condition). For completion, 
we have provided the remaining dataset of 2510 genes that 
appeared to show no change, or positive selection, in Table 
S4; of these, 273 mutants showed fewer than ten reads. Genes 
that were highly represented (high proportion of reads) in the 
untreated condition and poorly represented or absent in the 
treated condition (low proportion of reads) represent genes 
encoding proteins whose functions are important in toler-
ating sub-MIC ciprofloxacin (Fig. 1a). Examples of such genes 
include: manC, encoding a mannose-1-phosphate guanylyl-
transferase; gmd, encoding a GDP-mannose 4,6-dehydratase; 
fcl, encoding a GDP-l-fucose synthase; and wbyL, encoding 
a probable glycosyltransferase.
Interestingly, we observed a high number of genes relating to 
lipopolysaccharide (LPS) lipidA, O-antigen and core biosyn-
thesis as being negatively selected by ciprofloxacin treatment; 
these are highlighted and a full list of genes with a similar 
function is provided in Table 1.
When log2-fold change scores are applied to the data, it can 
be seen that the majority of genes are neither significantly 
positively nor negatively selected (0–1 log2-fold change) by 
the treatment condition (Fig. 1b). The ranked log2-fold change 
score for every gene in the genome is displayed graphically 
in Fig. 1(c), and particular genes of interest are highlighted.
While mutants that show a large drop in read count due to 
ciprofloxacin treatment exhibit a large log2-fold change, to 
only focus on these targets is to overlook transposon mutants 
that had a low read count following culture in the untreated 
condition. These may include genes involved in tolerance to 
ciprofloxacin, but also in general fitness as well, especially 
when cultured in competition with bacteria carrying a 
functional copy of the gene. Examples of such genes from 
this study include: folD, encoding a bifunctional protein; 
yptb2743, encoding an uncharacterized protein; and secF, 
encoding a protein-export membrane protein. This is not 
the only explanation for a low read count, and hence we 
tabulated these genes separately (Table S3), and any conclu-
sions regarding their role in antibiotic tolerance requires 
experimental confirmation. Similar caution must be applied 
to interpretation of genes displaying apparent positive selec-
tion, which may be a consequence of a proportional increase 
resulting from loss of negatively selected mutants from the 
pool.v
We therefore sought to further validate some of the TraDIS-
identified genes representing both high read-count and low 
read-count groups after untreated passage that still displayed 
negative selection under ciprofloxacin stress. We chose the 
genes: dksa (yptb0734) with −5.07 log2-fold change, and 
hda (yptb2792) with −2.61 log2-fold change. These genes 
were chosen as they are both predicted to have roles that are 
relevant to the mechanism of action of ciprofloxacin, namely 
in DNA repair and replication, and are 100 % conserved at 
the amino-acid level with Y. pestis. Replacement of the wild-
type genes with the kanamycin resistance cassette via lambda 
Red recombination was confirmed by PCR (Fig. 2). To ensure 
there were no polar effects resulting from the mutations that 
might affect the expression of flanking genes, we conducted 
RNA extraction and cDNA synthesis to use as template for 
PCR and gel electrophoresis and found that the flanking genes 
adjacent to dksA (sfsA and gluQ) and hdA (yptb2793 and arsC) 
were expressed normally (Fig. S2).
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Fig. 1. Graphical representation of Y. pseudotuberculosis transposon mutant library selection by ciprofloxacin treatment. Read counts 
for each gene following TraDIS were expressed as a proportion of the total read count across the entire genome either with or without 
ciprofloxacin treatment – selected genes showing negative selection by ciprofloxacin treatment are highlighted (a); log
2
-fold change 
ratios were calculated for every gene and their frequency was plotted to demonstrate the distribution of values, with most genes 
accounting for within a range of −1 and +1 fold change from the untreated control (b); the log
2
-fold change values for every gene in the 
genome were ranked and selected genes highlighted (c).
In vitro phenotypic characterization of dksA and hda 
mutants
The growth rates of both mutants at 28 °C in shaking culture 
in BAB medium was measured up to 24 h and demonstrated 
a statistically significant reduction in exponential growth 
rate relative to the wild-type, although this recovered by late 
exponential to early stationary phase (Fig. 3). This confirmed 
that the genes are not essential for survival of Y. pseudotuber-
culosis under in vitro growth conditions, as suggested by our 
previously published TraDIS data [18].
Upon treating with different antibiotics, we found that the 
IP32956 Δdksa::kanR and Δhda::kanR mutants were signifi-
cantly more sensitive to ciprofloxacin compared with the 
wild-type (Fig. 4). Furthermore, this was an antibiotic-specific 
effect, given that the mutants and wild-type did not show 
any significant difference in sensitivity to a related fluoroqui-
nolone, moxifloxacin, nor to two non-quinolone antibiotics, 
chloramphenicol and tetracycline, at equivalent concentra-
tions. Exposure to either H2O2 or cumyl hydroperoxide 
showed the IP32956 Δdksa::kanR mutant to be significantly 
more susceptible to chemically induced oxidative stress 
(Fig.  5a and b), while Δhda::kanR was significantly more 
susceptible to hydroxyurea, a DNA replication antagonist 
(Fig. 5c).
To broadly assess the sensitivity of the mutants to innate 
immune factors, murine IFNγ-activated macrophage-like 
RAW cells were infected at an m.o.i. of 0.1 for up to 24 h 
before bacterial c.f.u. was quantified from lysed cells (Fig. 6a). 
Both isogenic mutants were attenuated for survival intracel-
lularly compared with the wild-type, although this was not 
affected by the activation state of the host cell. Confirmation 
of the activation state of the cells was assessed by use of the 
Griess assay to measure nitrite, an indicator of nitric oxide 
production during cell culture (Fig. 6b).
In vivo phenotypic characterization of dksA and hda 
mutants
To assess a wider role in virulence for Hda and DksA, we 
utilized a G. mellonella larval infection model of Y. pseudo-
tuberculosis pathogenesis [24]. Briefly, ten larvae per group 
were injected with 1×106 c.f.u. of each strain or sterile PBS. 
Both survival and bacterial burden in the haemolymph was 
assessed up to 48 h. The median survival of larvae infected 
with the Δhda::kanR strain, but not the Δdksa::kanR strain, 
was significantly greater than larvae infected with the 
IP32956 control, with more larvae surviving at 48 h (Fig. 7a). 
However, there was no significant difference in the mean 
bacterial burden (as quantified by c.f.u. assay) in the larval 
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Table 1.  A selection of genes with related function required by Y. pseudotuberculosis to survive sub-MIC ciprofloxacin
Genes relating to LPS lipid A, O-antigen and core biosynthesis
Locus iD Gene name Predicted function
YPTB0051 kdtX Lipopolysaccharide core biosynthesis glycosyl transferase
YPTB0053 rfaC Lipopolysaccharide heptosyltransferase-1
YPTB0054 rfaF ADP-heptose-LPS heptosyltransferase II
YPTB0055 rfaD ADP-l-glycero-d-manno-heptose-6-epimerase
YPTB0172 rffG dTDP-glucose 4,6-dehydratase
YPTB0173 rffH Glucose-1-phosphate thymidylyltransferase
YPTB0175 rffA dTDP-4-amino-4,6-dideoxygalactose transaminase
YPTB0177 WecF TDP-N-acetylfucosamine:lipid II N-acetylfucosaminyltransferase
YPTB0229 livG ABC type branched-chain amino acid transport
YPTB0263 rfaH Transcription antitermination protein
YPTB0775 nlpD Lipoprotein
YPTB0998 ddhD CDP-6-deoxy-l-threo-d-glycero-4-hexulose-3-dehydrase reductase
YPTB1001 ddhC Putative CDP-4-keto-6-deoxy-d-glucose-3-dehydratase
YPTB1002 prt Paratose synthase
YPTB1003 wbyH Putative exported protein
YPTB1004 wzx Putative O-unit flippase
YPTB1005 YPTB1005 Uncharacterized protein
YPTB1006 wbyJ Putative mannosyltransferase
YPTB1008 wbyK Putative mannosyltransferase
YPTB1009 gmd GDP-mannose 4,6-dehydratase
YPTB1010 fcl GDP-l-fucose synthase
YPTB1011 manC Mannose-1-phosphate guanylyltransferase
YPTB1012 wbyL Probable glycosyltransferase
YPTB1453 ompA Outer membrane protein
YPTB1622 pagP Lipid A palmitoyltransferase
YPTB1914 YPTB1914 ABC sugar (sorbitol/trehalose/maltose) transporter, permease subunit
YPTB2014 YPTB2014 Putative ABC transporter
YPTB2327 pmrJ
Probable 4-deoxy-4-formamido-l-arabinose-phosphoundecaprenol 
deformylase
YPTB3041 ygeD Lysophospholipid transporter
YPTB3407 rfaE Bifunctional protein - ADP-l-glycero-beta-d-manno-heptose biosynthesis
YPTB3955 YPTB3955 ABC amino acid transporter
YPTB3964 glmS Glutamine-fructose-6-phosphate aminotransferase
YPTB3965 glmU Bifunctional protein GlmU
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Fig. 2.  Y. Pseudotuberculosis hda::kanR and dksa::kanR lack expression of wild-type hda and dksa. 1=dksa (a) or hda (b) -specific primers 
versus dksa::kanR or hda::kanR gDNA; 2=dksa (a) or hda (b) -specific primers versus wild-type IP32956 gDNA; 3=kanR-specific primers 
versus dksa::kanR or hda::kanR gDNA
Fig. 3. Growth rate of hda::kanR and dksa::kanR mutants. Wild-type or 
mutant Y. pseudotuberculosis were grown in fresh BAB liquid culture at 
28 °C and optical density (600 nm) was recorded over 24 h. Regression 
analysis was conducted and both hda::kanR (P<0.001, R2=0.98) and 
dksa::kanR (P<0.001, R2=0.97) strains were found to have significantly 
reduced growth rate.
haemolymph between the mutant and wild-type strains 
(Fig. 7b).
DISCuSSIon
Ciprofloxacin tolerance genes identified by TraDIS
Resistance to antibiotics is complex and multifactorial. 
TraDIS is now established as a robust molecular tool that 
enables genome-wide interrogation of gene essentiality in 
a given experimental condition. By treating a Y. pseudotu-
berculosis transposon library with sub-MIC concentrations 
of ciprofloxacin, we have revealed many more genes that are 
involved in tolerance to this antibiotic beyond the recognized 
target, DNA gyrase. These data reveal more subtle effects of 
ciprofloxacin-induced stress that expand our understanding 
of the drug–pathogen interface.
Our screen detected the requirement of multiple genes that 
may rationally be expected to contribute to the processes 
that are disrupted by ciprofloxacin, namely DNA replication 
and repair [25]. These include, for example, recB/C/G, ruvB, 
nrdA/B and holE, some of which have been shown to be 
upregulated upon treatment with quinolones in other bacte-
rial species [26, 27] and contribute to bacterial persistence 
in the presence of these antibiotics [28]. Functional loss of 
these genes combined with ciprofloxacin stress significantly 
harms the ability of the bacteria to cope with even sub-MIC 
concentrations of the antibiotic. Surprisingly, the importance 
of DNA repair mechanisms in tolerating quinolones has only 
relatively recently come to be appreciated, with the emphasis 
being point mutations at the DNA gyrase and topoisomerase 
target site [29–31].
We also identify a number of genes likely to encode efflux 
transporters, such as rosA, qacE, mepA and yptb3307, that are 
probably involved in preventing cytoplasmic accumulation 
of the drug [32].
As well as reinforcing current understanding of resistance 
to ciprofloxacin, our TraDIS screen identified genes that 
might point to novel or under-appreciated mechanisms 
of resistance. For example, we find multiple genes relating 
to the synthesis and function of molybdenum-containing 
enzymes. These have hitherto had no reported role in resist-
ance to antibiotics, but have various roles relating to oxida-
tive and reductive catalytic activity [33]. We furthermore 
identify genes involved in urease synthesis, enzymes whose 
activity has variously been reported to be both enhanced 
[34] and inhibited [35] by ciprofloxacin in different species. 
An interesting finding is the requirement for dps, encoding 
DNA protection during starvation protein. This has been 
reported to bind non-specifically to the chromosome and 
protect nucleotides from oxidative-stress-induced strand 
breakages [36]. The requirement of genes encoding Xer 
tyrosine recombinases (yptb3167 and yptb0192) may reflect 
their ability to resolve dimeric chromosomes arising from 
stalled replication that may be more common in the presence 
of ciprofloxacin. Supporting this, we also find a requirement 
for ftsK, a gene encoding a cell division protein that has 
recently been described as an accessory to Xer recombinases 
[37]. We also identify several genes of unknown function 
whose transposon mutants are strongly negatively selected 
by ciprofloxacin treatment.
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Fig. 4.  Y. Pseudotuberculosis hda::kanR and dksa::kanR are significantly more sensitive than the wild-type to ciprofloxacin. Y. 
pseudotuberculosis wild-type strain IP32956 and mutants identified as ciprofloxacin-sensitive by TraDIS were treated with ciprofloxacin 
or alternative antibiotics for 16 h and then subjected to alamar blue metabolic assay (a) or plated for c.f.u. enumeration (b). For metabolic 
assays, values are all normalized relative to the untreated condition for each strain. All statistical comparisons are Student’s t-test 
versus the wild-type strain for the same antibiotic treatment condition (*P<0.01)
Sub-mIC ciprofloxacin causes broad cell envelope 
stress
It was observed as early as 1987 that sub-MICs of quinolone 
antibiotics could alter the outer membrane (OM) composi-
tion of bacteria, modifying the phospholipid to amino acid 
ratio [38]. We can now report evidence in support of this at 
the genomic level.
Among the transposon mutants that showed the greatest 
loss of fitness during ciprofloxacin treatment are multiple 
genes relating to LPS lipid A, O-antigen and core biosyn-
thesis. These include the O-antigen operon itself, as well as 
associated glycosyltransferases, transcriptional regulators, 
ATP synthases, ABC transporters, and sugar and lipoprotein 
biosynthetic genes. A role for the O-antigen might suggest 
that different isotypes or species respond differently to the 
antibiotic, considering this is hypermutable region of the 
genome, and has been deactivated entirely in Y. pestis.
Since ciprofloxacin is hydrophilic, the core region of LPS 
represents an impermeable barrier, and therefore it is logical 
that maintenance of the OM is required to exclude the anti-
biotic, restricting its entry to porin channels, which can in 
turn be regulated by the bacteria. Yet besides porin-mediated 
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Fig. 5.  Y. Pseudotuberculosis dksa::kanR and hda::kanR are sensitive to oxidative stress and inhibition of DNA replication, respectively. 
Bacterial strains were incubated with a titration of either cumyl hydroperoxide (a), hydrogen peroxide (b) or hydroxyurea (c) in fresh 
BAB liquid culture at 28 °C for 24 h prior to assessment of bacterial growth by optical density. Values are all normalized relative to the 
untreated condition for each strain. All statistical comparisons are Student’s t-test versus the wild-type strain for the same antibiotic 
treatment condition (*P<0.01).
uptake, quinolones have been reported to permeabilize the 
OM directly via displacement of divalent cation linkages in 
the LPS, similar to the action of polymyxin B. Resistance to 
this includes modification of the lipid A charge, for example 
by esterification with amino-arabinose. Interestingly, we 
observe the requirement of a deformylase, pmrJ, likely to 
be responsible for the attachment of modified arabinose to 
lipid A [39]. A further example of lipid A modification is its 
palmitoylation by the transferase pagP (a pseudogene in Y. 
pestis), which we also identified as a ciprofloxacin tolerance 
gene. The additional reported role of palmitoylation of lipid A 
in resistance to host immune effectors highlights it as part of 
general adaptation to myriad stressors, including antibiotics, 
and make it an attractive target for new antimicrobial design.
Also indicative of OM stress is the requirement of two genes 
that have been associated with PagP activity, and which 
have been found to be upregulated following perturbation 
of the O-antigen: the ơE regulatory factor and cpx, part of a 
two-component system. Cpx is reportedly able to upregulate 
efflux systems, and may also be required for optimal type III 
secretion in Yersinia species [40].
A peculiarity in our data is the finding that ompA, encoding 
a porin, is actually required to resist sub-MIC ciprofloxacin. 
However, unlike OmpF/C, OmpA does not form a highly 
porous trimeric channel, but rather a monomeric beta-barrel 
structure with much smaller pore size and lower permeability 
[41]. In fact, OmpA may instead have an essential role in 
maintaining LPS stability under stress conditions [42], poten-
tially serving as an anchor between the OM and periplasmic 
peptidoglycan (PGN) [43]. This potentially mirrors the pres-
ence in our data of other major OM lipoprotein genes such as 
lpp, yptb3358 and yptb3313, as well as members of the general 
secretion pathway (gspJ/G/D) encoding proteins that traverse 
the OM, periplasm and inner membrane. A secondary role 
for such uptake and secretory transmembrane proteins in 
ameliorating membrane disruption by conferring mechanical 
stability requires further study.
Taken together, our data show that even at sub-MIC, cipro-
floxacin induces fundamental changes to the physiology of 
the bacterial LPS, which requires the collective activity of a 
multitude of host genes to cope with.
The DnA replication and repair genes, DksA and 
HDA, are required for ciprofloxacin tolerance
As described in our methodology, we stratified our TraDIS 
data into two distinct groups: ciprofloxacin-sensitive mutants 
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Fig. 6. Dksa and hda contribute to intracellular fitness. An m.o.i. of 0.1 was 
used to infect IFNγ-activated murine RAW 264.7 cells for 1 h, followed 
by washing (T=0) and lysis after 24 h (T=24) before enumeration by 
c.f.u. (a). Extracellular growth was controlled by using 100 µg imipenem 
ml−1. Before and during cell infection, cells were treated or not with IFB 
and cell activation was measured indirectly by quantification of nitrite 
in culture supernatant by Griess assay (b). All statistical comparisons 
are Student’s t-test versus the wild-type strain for the same antibiotic 
treatment condition (*P<0.01) (a) or between activated versus resting 
macrophages at each time point (b).
Fig. 7. hda::kanR and dksa::kanR have attenuated virulence in vivo. In 
total, 1×106 Y. pseudotuberculosis wild-type, mutant bacilli or sterile 
PBS control were injected into Galleria mellonella larvae and survival 
was quantified over 48 h (a). Post-mortem, bacterial burden in the 
haemolymph was assessed and enumerated by a c.f.u. assay (b). All 
statistical comparisons are Student’s t-test of survival groups for each 
condition at 48 h versus 24 h (*P<0.01).
that showed no defect in general fitness when cultured with 
the entire pooled transposon library; and ciprofloxacin-sensi-
tive mutants that showed reduced fitness in co-culture with 
the transposon library without antibiotic. A representative 
gene from each group was examined for a potential role in 
ciprofloxacin sensitivity as confirmation of our TraDIS data.
ΔdksA::kanR and Δhda::kanR were significantly more sensi-
tive than wild-type Y. pseudotuberculosis to sub-MIC cipro-
floxacin. To our knowledge, this is the first report to describe 
a role for either gene in ciprofloxacin tolerance. Novel 
compounds that inhibit the function of such genes may offer 
synergistic benefit when coupled with existing antibiotics, 
similar to the use of beta-lactamase inhibitors that increase the 
efficacy of penicillin-related compounds [44]. The precision 
of TraDIS is exemplified by the finding that the two mutants 
were sensitive to ciprofloxacin, but not to other antibiotics. 
Even though moxifloxacin is also a quinolone-class drug, it 
additionally targets ParC of topoisomerase IV rather than 
just GyrA; DksA and Hda may hence have a comparatively 
restricted role in tolerance to this antibiotic.
DksA acts as a regulator of RNA polymerase; in conjunction 
with RecN protein, it is able to sense and repair double-strand 
breaks in DNA [45] and prevent collisions occurring between 
the transcription elongation complex and the replication 
fork [33, 34]. Since ciprofloxacin stabilizes the gyrase–DNA 
complex at the replication fork [46], the likelihood of colli-
sions with the transcription elongation complex increases, 
causing chromosomal damage [42]. DNA gyrase also relaxes 
torsion stress caused by the unwinding of supercoiled DNA 
by initiating double-strand breaks, which may increase after 
ciprofloxacin treatment [42, 47]. Therefore, DksA has an 
important housekeeping role that is especially sensitive to 
disruption by ciprofloxacin.
We confirmed the importance of DksA to DNA repair by 
modelling chemically induced oxidative stress. Aerobic 
prokaryotes have evolved to cope with naturally occurring 
endogenous reactive oxygen species (ROS) such as H2O2 [48]. 
H2O2 does not damage DNA directly, but upon reacting with 
cellular iron, generates radicals that can oxidize DNA and 
induce single-strand breaks that must be repaired by the Rec 
system [48]. Similarly, cumene hydroperoxide has been shown 
to induce DNA-repair mechanisms, and interestingly, also 
drug efflux proteins [49]. ROS have been shown to contribute 
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to quinolone-mediated cell death in Escherichia coli [50, 51], 
and there is emerging evidence that several other antibiotics 
may similarly induce lethal oxidative DNA damage [52]. This 
highlights the prominent role for genes that contribute to 
broad functions from housekeeping to managing oxidative 
and antibiotic stress.
While DksA plays a role in DNA repair, Hda (yptb2792) 
inactivates the DNA replication initiation factor, DnaA [53], 
and was also found to contribute to ciproflocaxin tolerance. 
An apparent reduction in exponential-stage growth in broth 
culture may partly account for diminished representation of 
the Δhda::kanR mutant from the pooled, untreated trans-
poson library. DnaA recruits replication machinery to the 
chromosomal origin of replication (OriC) site to form an 
initiation complex [41, 42]; without careful regulation, poten-
tially lethal rounds of erroneous initiation cycles can occur 
[43, 54]. The importance of regulation of DNA replication 
to ciprofloxacin tolerance is also supported by our finding 
of the apparent requirement for both diaA (yptb3495) and 
dam (yptb1863). DiaA regulates the timely recruitment of 
DnaA, preventing aberrant rounds of asynchronous initia-
tion [55]. Dam has a similar role: DNA replication results in 
hemi-methylated strands of DNA that resist DnaA binding 
and prevent immediate re-initiation at the OriC; Dam restores 
full methylation at these sites, enabling DNA replication 
to proceed [55]. Temporal regulation of DNA replication 
by factors such as Hda, DnaA and Dam may contribute to 
ciprofloxacin tolerance by preventing collisions between the 
replication fork and the elongation complex, similar to DksA.
Pauses in the replication cycle are also necessary to enable 
DNA repair to take place, allowing the bacteria to cope with 
any ciprofloxacin-induced damage [56]. DNA replication and 
repair are naturally linked by a shared resource: dNTPs; thus, 
orderly DNA replication mediated by Hda may ensure a pool 
of dNTPs are present for utilization in DNA repair pathways. 
HU depletes dNTPs, preventing both their incorporation into 
the nascent DNA strand and their use in DNA repair [56]. 
The Δhda::kanR mutant may be significantly more sensitive to 
HU because the replication fork is arrested, a similar outcome 
to ciprofloxacin treatment. Interestingly, HU-mediated cell 
death has been reported to replicate some of the same pertur-
bations as caused by ciprofloxacin, including oxidative and 
cell-envelope stress [57].
Dksa and Hda contribute to virulence
Considering the significant roles of DksA and Hda in DNA 
replication and repair under ciprofloxacin and oxidative 
stress, we hypothesized that they may also be important in 
resistance to host-mediated innate immune stress. DksA has 
been proposed to sense ROS and reactive nitrogen species 
(RNS) in Salmonella sp. [32]. It controls 427 genes in response 
to stress related to aspects of cellular metabolism, and several 
antioxidants and oxidoreductases important in redox buff-
ering [58]. Supporting our hypothesis, we found reduced 
survival of both mutants in murine macrophage-like RAW 
264.7 cells. Interestingly, this was not affected by the activation 
state of the cell at the time of infection, despite demonstrating 
enhanced production of nitric oxide. Partly this may be due 
to the attenuation of the mutants even in resting cells; in 
addition, the resting cells still became activated over time 
simply due to the presence of the bacteria. Impaired intra-
cellular growth of the Yersinia mutants may partly explain 
the reduced virulence of the Δyptb2792::kanR strain in the 
G. mellonella larval infection model. Interestingly, however, 
there was no significant difference in overall bacterial burden 
post-mortem. This could be due to extracellular replication of 
bacteria that masked any differences in intracellular growth.
Conclusion
We have utilized TraDIS to identify novel genes with a role 
in tolerating sub-lethal concentrations of ciprofloxacin. In 
contrast to the notion that ciprofloxacin has a narrow target 
of action, our data highlight the broad stress induced by the 
antibiotic, especially with regard to cell envelope integrity. 
In particular, Y. pseudotuberculosis depends upon genes 
involved in DNA replication and repair to cope with cipro-
floxacin treatment. Perturbation of two of these genes, hda 
and dksA, significantly enhanced the sensitivity of bacteria 
to ciprofloxacin. In principle, antagonistic compounds for 
targets such as these could be used to reduce the effective 
MIC of the antibiotic during therapeutic use.
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